Return On Assets of ZyVersa Therapeutics, Inc. from 12 Dec 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
ZyVersa Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 12 Dec 2022 to 30 Sep 2025.
  • ZyVersa Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -165%, a 60% decline year-over-year.
  • ZyVersa Therapeutics, Inc. annual Return On Assets for 2024 was -46%, a 76% increase from 2023.
  • ZyVersa Therapeutics, Inc. annual Return On Assets for 2023 was -195%, a 1137% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

ZyVersa Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -165% -62% -60% 01 Jul 2025 30 Sep 2025
Q2 2025 -41% +50% +55% 01 Apr 2025 30 Jun 2025
Q1 2025 -44% +315% +88% 01 Jan 2025 31 Mar 2025
Q4 2024 -46% +148% +76% 01 Oct 2024 31 Dec 2024
Q3 2024 -103% +11% +9.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -91% +5% +5.4% 01 Apr 2024 30 Jun 2024
Q1 2024 -359% -355% -7409% 01 Jan 2024 31 Mar 2024
Q4 2023 -195% -194% -37101% 01 Oct 2023 31 Dec 2023
Q3 2023 -114% 01 Jul 2023 30 Sep 2023
Q2 2023 -96% 01 Apr 2023 30 Jun 2023
Q1 2023 -5% 01 Jan 2023 31 Mar 2023
Q4 2022 -1% 13 Dec 2022 31 Dec 2022

ZyVersa Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -46% +148% +76% 01 Jan 2024 31 Dec 2024
2023 -195% -179% -1137% 01 Jan 2023 31 Dec 2023
2022 -16% 01 Jan 2022 12 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.